New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective …
Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.”
Patients …
APA has released a list of cautionary principles that should be considered when prescribing antipsychotic medications, noting that they are sometimes prescribed inappropriately.…
A study in this month’s Psychiatric Services examined the association between patients’ preexisting metabolic risk factors and the physician’s choice of antipsychotic agent based on its propensity to cause metabolic side effects.
Over a span of 3 years, 1,898 office-based …
According to a new study in Psychological Medicine, people treated in psychiatric settings are receiving inadequate medical monitoring while taking antipsychotic medication
New research from the University of Leicester demonstrates that psychiatrists are not offering adequate checks for metabolic …
